Vectus Biosystems

Vectus Biosystems Limited (VBS) is a public company based at Julius Avenue, North Ryde, Sydney, Australia.

Vectus has developed potentially novel treatments for fibrosis and high blood pressure which include treatment for three of the largest diseases in the fibrotic franchise, namely heart, kidney and liver disease.

Contact Details

3-11 Primose Avenue , ROSEBERY NSW 2018

02 9662 4144

info@vectusbiosystems.com.au

www.vectusbiosystems.com.au

Lists and Charts

Share price

Vectus Biosystems
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1766^th	Lucapa Diamond Company	-75.29%	-40.43%
1767^th	Oceana Lithium	-75.47%	0%
1768^th	Vectus Biosystems	-75.56%	-33.24%
1769^th	Tyranna Resources	-75.93%	-4.66%
1770^th	QEM	-75.95%	-13.32%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: Maurie Stang, Non-Executive Deputy Chair	03 Nov 2020
	NEW ROLE: Ronald C Shnier, Non-Executive Director, Non-Executive Chairman	03 Nov 2020
	NEW ROLE: Peter Bush, Non-Executive Director	03 Nov 2020
	NEW ROLE: Susan Pond, Non-Executive Director	03 Nov 2020
	NEW ROLE: Karen A Duggan, Chief Executive Officer, Executive Director	03 Nov 2020
	NEW ROLE: Robert Waring, Company Secretary	03 Nov 2020

Related Information

Access to our data for Vectus Biosystems is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Vectus Biosystems is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today